Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-12-03T19:39:10.401Z Has data issue: false hasContentIssue false
  • English
  • Français

An Investigation of the Adrenocortical Response of Mental Patients to E.C.T. and Insulin Hypoglycaemia

Published online by Cambridge University Press:  08 February 2018

F. Mackenzie Shattock  and
Lorna P. Micklem
F. Mackenzie Shattock
Affiliation:
Clinical Research Unit, Three Counties Hospital, Arlesey, Beds
Lorna P. Micklem
Affiliation:
Clinical Research Unit, Three Counties Hospital, Arlesey, Beds
Get access Rights & Permissions [Opens in a new window]

Extract

Somatic disturbances in schizophrenia include metabolic, circulatory and endocrine changes frequently associated with disorders of the pituitary gland and adrenal cortex. Depression of the metabolic rate is often severe (Hoskins, 1932), the systolic blood-pressure is sometimes as low as 80 mm. Hg (Hoskins, 1934; Rheingold, 1939; Shattock, 1950), and the pulse pressure only a few millimetres. Peripheral vascular deficiency and atrophy of the tissues (Bleuler, 1920; Mapother, 1924; Minski, 1937; Shattock, 1950), asthenia and various cutaneous changes are common; amenorrhoea is almost the rule.

It is remarkable that these disturbances are reversible, and that they are relieved or greatly alleviated during mental remission. Physical health is restored during a spontaneous remission, and a gradual improvement can be observed during a course of insulin comas. Sometimes a dramatic recovery follows electroconvulsion when this initiates a mental remission; somatic improvement is then rapid and the vascular deficiency may be relieved within a few hours (Shattock, 1950). Unfortunately these remissions are often brief, and as relapses become more frequent after repeated treatment, physical and mental deterioration may be noticeable a few days after the initial improvement. The point of interest is a concordance of physical and mental changes, and not the therapeutic value of E.C.T. used as an adjunct to insulin treatment or as a means of moderating extreme restlessness in chronic patients.

Type
Part I.—Original Articles
Information
Journal of Mental Science , Volume 98 , Issue 411 , April 1952 , pp. 287 - 293
Copyright
Copyright © Royal College of Psychiatrists, 1952 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ashby, R. W., J. Ment. Sci., 1949, 95, 275.CrossRefGoogle Scholar
Idem, ibid., 1952, 98, 81.Google Scholar
Altschule, M. D., Parkhurst, B. H., and Tillotson, K. J., J. Clin. Endocrinol., 1949, 9, 440.CrossRefGoogle Scholar
Bleuler, E., Lehrbuch der Psychiatrie, 1920.CrossRefGoogle Scholar
Bornstein, J., and Trewhella, P., Lancet, 1950, ii, 678.Google Scholar
Idem and Gray, C. H., ibid., 1951, i, 237.Google Scholar
1 Cope, C. L., Brit. Med. J., 1951, i, 271.Google Scholar
2 Idem, Boysen, X., and McCrae, S., ibid., 1951, ii, 762.Google Scholar
Davidson, L. S. P., ibid., 1951, ii, 294.Google Scholar
Early, D. F. M., Hemphill, R. E., Maggs, R., Reiss, M., Steele, G. D., Cook, E. R., and Pelly, J. E., J. Endocrinol., 1951, 7 (Proc. Soc. Endocrinol.), xviii.Google Scholar
Godlowski, Z. Z., Brit. Med. J., 1951, i, 854.CrossRefGoogle Scholar
Hills, A. G., Forsham, P. H., and Finch, C. A., Blood, 1948, 3, 755.Google Scholar
Hoagland, H., Callaway, E., Elmadjian, F., and Pincus, J., Psychosom. Med., 1950, 12, 73.CrossRefGoogle Scholar
Hoskins, R. G., Arch. Neurol. Psychiat., 1932, 28, 1346.CrossRefGoogle Scholar
Idem and Jellinek, E. M., Proc. Ass. Res. Nerv. and Ment. Dis., 1934, 14, 211.Google Scholar
Kay, W. W., and Thorley, A. S., Proc. Roy. Soc. Med., 1951, 44, 973.Google Scholar
Kersley, G. D., Mandel, L., Jeffrey, M. R., Desmarais, M. H. L., and Bene, E., Brit. Med. J., 1950, ii, 855.CrossRefGoogle Scholar
Mapother, E., Lancet Extra Number, 1924, No. 2, p. 81.Google Scholar
Minski, L., J. Ment: Sci., 1937, 83, 437.CrossRefGoogle Scholar
Morris, C. J. O. R., Lancet, 1951, i, 161.CrossRefGoogle Scholar
Osgood, E. E., and Seaman, A. J., Physiol. Rev., 1944, 24, 46.CrossRefGoogle Scholar
Parsons, E. H., Gildea, E. F., Ronzoni, E., and Hulbert, S. Z., Am. J. Psychiat., 1949, 105, 573.CrossRefGoogle Scholar
Pincus, G., Hoagland, H., Freeman, H., Elmadjian, F., and Romanoff, L. P., Psychosom. Med., 1949, 11, 74.CrossRefGoogle Scholar
Randolph, T. G., J. Lab. Clin. Med., 1949, 34, 1696.Google Scholar
Idem, Clinical ACTH, ed. Mote, , 1950, p. 13, London.Google Scholar
Recant, L., Hume, D. M., Forsham, P. H., and Thorn, G. W., J. Clin. Endocrinol., 1950, 10, 187.CrossRefGoogle Scholar
Rheingold, J. C., Psychosom. Med., 1939, 1, 397.CrossRefGoogle Scholar
Rowntree, D. W., and Kay, W. W., J. Ment. Sci., 1952, 98, 100.CrossRefGoogle Scholar
Rud, F., Acta Psychiat. et Neurol. (suppl. 40), 1947.Google Scholar
Sackler, R. R., Sackler, M. H., Sackler, A. M., Greenberg, D., Van Ophuijsen, J. H., and Tui, , Co, , Proc. Soc. Exp. Biol. Med., 1951, 76, 226.CrossRefGoogle Scholar
Sayers, M. A., Sayers, G., and Woodbury, L. A., Endocrinol., 1948, 42, 379.CrossRefGoogle Scholar
Sayers, G., Physiol. Rev., 1950, 30, 241.CrossRefGoogle Scholar
1 Shattock, F. M., J. Ment. Sci., 1950, 96, 32.CrossRefGoogle Scholar
2 Idem , Proc. Roy. Soc. Med., 1950, 43, 623.CrossRefGoogle Scholar
Speirs, R. S., and Meyer, R. K., Endocrinol., 1949, 45, 403.CrossRefGoogle Scholar
Thorn, G. W., Forsham, P. H., Prunty, F. T. G., and Hills, A. G., J.A.M.A., 1948, 137, 1005.CrossRefGoogle Scholar
Whitby, L. E., and Britton, C. J., Disorders of the Blood, 1947, 5th ed., London.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.